AMGN vs SG · P/E 24, rev $10.05B vs P/E 71, rev $679.5M
Amgen Inc (AMGN) versus Sweetgreen Inc (SG) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Sweetgreen Inc (SG) is a restaurants company listed on NYSE.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported SG revenue for 2025-12-28 was $679.5M. Net income was -$134.1M. Revenue was up 0.4% from 2024-12-29 to 2025-12-28. SG currently screens at market cap $1.01B and trailing P/E 71.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. SG currently screens at market cap $1.01B and trailing P/E 71.0.
Not investment advice. Open the AMGN and SG stock pages for the full models.
Not investment advice.